Former Israeli PM Barak to Chair Medical Marijuana Company

10w
1m read
Summary

AdvertisementSupported byFormer Israeli PM Barak to Chair Medical Marijuana CompanyBy The Associated PressSept. 26, 2018JERUSALEM — Former Israeli Prime Minister Ehud Barak has been appointed chairman of an Israeli medical marijuana company.The company, InterCure, announced Wednesday that Barak would be coming on board as chairman. Barak, who served as prime minister in the early 2000s as well as defense minister, has remained in the public eye since leaving politics, often criticizing government policies.InterCure says Barak will lead its global growth strategy. In a statement, it said Barak's "stature" will be helpful for the company's development.The company, which is publicly traded in Israel, intends to change its name to Canndoc Pharma.Israel has attempted to position itself as a global leader in medical marijuana. It has long permitted marijuana for medical use and has been considering allowing the industry to export.TrendingErin Schaff for The New York TimesBefore Kavanaugh Hearing, New Accusations and Doubts EmergeRyan Pfluger for The New York TimesBradley Cooper Is Not Really Into This ProfileTom Brenner for The New York Times5 Takeaways From Trump’s News Conference at the United Nationsvia Senate Judiciary CommitteeBret StephensOpinion: This Revolution, Too, Will Eat Its ChildrenAlex Brandon/Associated PressDebunking 5 (More) Viral Rumors About Kavanaugh’s AccusersRead Christine Blasey Ford’s Prepared StatementAdvertisement

Article Preview

Advertisement

Supported by

Former Israeli PM Barak to Chair Medical Marijuana Company

By The Associated Press

Sept. 26, 2018

JERUSALEM — Former Israeli Prime Minister Ehud Barak has been appointed chairman of an Israeli medical marijuana company.

The company, InterCure, announced Wednesday that Barak would be coming on board as chairman. Barak, who served as prime minister in the early 2000s as well as defense minister, has remained in the public eye since leaving politics, often criticizing government policies.

InterCure says Barak will lead its global growth strategy. In a statement, it said Barak's "stature" will be helpful for the company's development.

The company, which is publicly traded in Israel, intends to change its name to Canndoc Pharma.

Israel has attempted to position itself as a global leader in medical marijuana. It has long permitted marijuana for medical use and has been considering allowing the industry to export.

Trending

Erin...

Read the full article @ NY Times